Table 1.
Characteristicsa | 2006, n=100,809, % | 2007, n=133,323, % | 2008, n=140,174, % | 2009, n=143,217, % | 2010, n=153,758, % |
---|---|---|---|---|---|
Opioid prescription | |||||
None | 36.9 | 37.4 | 37.1 | 36.6 | 36.0 |
Short term | 43.1 | 42.4 | 41.5 | 41.0 | 40.6 |
Chronic | 20.0 | 20.2 | 21.4 | 22.3 | 23.4 |
Analgesic prescription | |||||
Yes | 15.2 | 14.2 | 13.9 | 14.0 | 14.2 |
Age group, yr | |||||
20–44 | 19.3 | 17.4 | 17.1 | 16.8 | 16.4 |
45–64 | 42.5 | 42.2 | 42.5 | 43.1 | 43.5 |
65+ | 38.2 | 40.4 | 40.5 | 40.1 | 40.2 |
Sex | |||||
Men | 49.4 | 51.4 | 51.8 | 51.9 | 52.2 |
Race | |||||
Black | 45.8 | 43.7 | 42.9 | 42.4 | 42.0 |
White | 48.1 | 50.6 | 51.3 | 51.8 | 52.2 |
Other | 6.1 | 5.8 | 5.8 | 5.8 | 5.8 |
Dual statusb | |||||
Yes | 85.3 | 72.6 | 71.8 | 71.3 | 70.9 |
Residential area | |||||
Large metropolitan | 52.0 | 50.9 | 51.0 | 51.2 | 51.3 |
Medium/small metropolitan | 28.9 | 29.7 | 29.7 | 29.8 | 29.7 |
Nonmetropolitan | 19.1 | 19.5 | 19.4 | 19.1 | 19.0 |
ESRD vintage, yr | |||||
1–2 | 18.0 | 18.1 | 17.1 | 16.9 | 16.6 |
3–4 | 31.3 | 31.2 | 31.3 | 30.5 | 29.6 |
5+ | 50.8 | 50.7 | 51.7 | 52.7 | 53.8 |
Dialysis modalityc | |||||
HD | 94.6 | 94.2 | 94.3 | 94.4 | 94.3 |
History of kidney transplantation | |||||
Yes | 7.9 | 7.6 | 7.7 | 7.7 | 7.6 |
Nursing home residenced | |||||
Yes | 11.4 | 10.5 | 11.0 | 11.0 | 11.5 |
Cancere | |||||
Yes | 4.4 | 4.9 | 5.1 | 5.3 | 5.4 |
Prior pain-related hospitalization | |||||
Yes | 5.1 | 5.5 | 6.0 | 6.0 | 6.7 |
No. of prior hospitalizations | |||||
0 | 38.8 | 40.3 | 40.9 | 41.4 | 41.9 |
1–2 | 34.6 | 35.3 | 34.4 | 34.3 | 34.5 |
3–4 | 14.7 | 14.0 | 13.7 | 13.5 | 13.4 |
5 or more | 11.9 | 10.5 | 11.0 | 10.8 | 10.2 |
The same patient might have been included in multiple years.
Dual status in Medicare and Medicaid.
The last modality in the study year.
On the basis of one or more claims in physician/carrier files.
On the basis of one or more inpatient stays with a cancer diagnosis and CMS Form 2728.